Related Experiment Video
Updated: Feb 20, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Association of Classic Cardiovascular Risk Factors and Lifestyles With the Cardio-ankle Vascular Index in a General
Marc Elosua-Bayés1, Ruth Martí-Lluch2, María Del Mar García-Gil3
1Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain.
Insights
The cardio-ankle vascular index (CAVI) increases with age and is higher in men, correlating with cardiovascular risk factors. Higher CAVI is linked to hypertension, diabetes, and obesity, suggesting its potential as a predictive biomarker.
Area of Science:
- Cardiovascular Health
- Vascular Biology
- Biomarker Research
Background:
- Arterial stiffness is a key indicator of cardiovascular health.
- The cardio-ankle vascular index (CAVI) is a measure of arterial stiffness.
- Understanding CAVI distribution in diverse populations is crucial for risk assessment.
Purpose of the Study:
- To describe CAVI distribution in a Mediterranean population.
- To determine CAVI prevalence by sex and coronary risk.
- To assess CAVI associations with cardiovascular risk factors and lifestyle.
Main Methods:
- Cross-sectional study in Girona province, Spain.
- CAVI measured using the VaSera VS-1500 device.
- Analysis included 2613 adult participants.
Main Results:
- Prevalence of CAVI ≥ 9 was 46.8% in men and 36.0% in women.
- CAVI increased with age and coronary risk level in both sexes.
- CAVI ≥ 9 associated with hypertension, diabetes, and BMI in men; hypertension, hypercholesterolemia, and obesity in women.
Conclusions:
- CAVI increases with age and is higher in men.
- CAVI is associated with traditional cardiovascular risk factors and coronary risk.
- CAVI shows potential as a cardiovascular risk stratification biomarker, warranting further research.
Introduction And Objectives:
The cardio-ankle vascular index (CAVI) assesses arterial stiffness. We aimed to describe the distribution of CAVI in a Mediterranean population, to determine the proportion of CAVI ≥ 9 by sex and coronary risk level, and to assess the association of CAVI with classic cardiovascular risk factors and lifestyle patterns.
Methods:
This cross-sectional study was based on the population of Girona province. The CAVI was measured using the VaSera VS-1500.
Results:
Of 2613 individuals included in this study, the prevalence of CAVI ≥ 9 was 46.8% in men and 36.0% in women and significantly increased with coronary risk: from 21.1% and 24.8%, respectively to 76.7%, in the low-risk group, and 61.9% in the high-risk group. The CAVI increased with age in both sexes, being higher in men across all age groups. In men, CAVI ≥ 9 was associated with hypertension (OR, 2.70; 95%CI, 1.90-3.87) and diabetes (OR, 2.38; 95%CI, 1.52-3.78), body mass index (BMI) ≤ 25 to < 30 (OR, 0.44; 95%CI, 0.27-0.72) and BMI ≥ 30 (OR, 0.28; 95%CI, 0.14-0.58), and physical activity (OR, 0.66; 95%CI, 0.47-0.92). In women, CAVI ≥ 9 was associated with hypertension (OR, 2.22; 95%CI, 1.59-3.09), hypercholesterolemia (OR, 1.40; 95%CI, 1.01-1.94), and BMI ≥ 30 (OR, 0.38; 95%CI, 0.20-0.71).
Conclusions:
The CAVI increases with age and is higher in men than in women. This index is associated with classic risk factors and coronary risk. It could be a good predictive biomarker, but further follow-up studies are required to assess its added value to cardiovascular risk stratification.
Related Concept Videos
Coronary Artery Disease I: Introduction
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

